Lightphorin Eye Drops (Cyclosporine) (Single Use)

Adult eye dose

Instill 1 drop into each eye 2 times daily, approximately 12 hours apart. Before use, turn the container upside down and back to mix until the suspension is a uniform white, opaque emulsion. If using this medicine at the same time as artificial tears, administer them 15 minutes apart. Discard any remaining solution and the container after instillation.

This medication has not been sufficiently studied for use in patients with a history of herpetic keratitis, and caution is advised. Patients using local anti-inflammatory medications or tear duct plugs showed no increase in tear production. This medication should not be administered to patients with active ocular infections or those who have or are suspected to have allergies to this product's ingredients. The most commonly experienced side effect while using this medication may be a stinging sensation in the eye. Other possible side effects include conjunctival hyperemia, ocular discharge, tearing, eye pain, foreign body sensation, itching, irritation, and blurred vision. Rarely, serious reactions such as ocular swelling, severe allergic reactions, ocular surface damage, or hives have been reported. This medication should be used only for ophthalmic purposes and caution should be taken to avoid contact between the tip of the container and the eye. Vision may become temporarily blurred post-instillation, so driving or operating dangerous machinery is advised against. The safety of this medication has not been established during pregnancy, thus it should be used cautiously only if necessary. There is no research on whether this medication is excreted in breast milk, so it should be used carefully in nursing mothers. Safety and efficacy have not been established for children under 16 years old, so its use is not recommended. Open containers should be used only once, and any remaining medication discarded while ensuring the tip of the container does not become contaminated. This medication should not be used while wearing contact lenses; lenses should be removed prior to instillation and can be reinserted after 15 minutes post-administration. Medications should be kept out of reach of children, and expired medications should be disposed of properly. Systemic carcinogenic studies showed some tendency for cancer development in animal studies, but the dose of this medication used in the eyes is very low, suggesting minimal impact on humans. This medication has not shown mutagenic or genotoxic effects, and no infertility phenomena were reported in reproductive toxicity studies.

• burning sensation in the eyes
• conjunctival hyperemia
• discharge
• epiphora
• ocular pain
• foreign body sensation
• itching
• pain in the eye
• visual disturbances
• eye swelling

This medication must be stored in a tightly sealed container to protect it from air and moisture exposure. It is also crucial to maintain a room temperature between 15 to 25 degrees Celsius when storing the medication to ensure its effectiveness over time.

Appearance

A white opaque or slightly translucent homogeneous liquid contained in a white translucent plastic vial.

Package unit

30 tubes / box [(0.4 milliliters / tube)]